Results 221 to 230 of about 313,710 (255)

Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents

Pharmacology & Therapeutics, 1999
Alexander Levitzki
exaly  

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

European Journal of Medicinal Chemistry, 2004
Pascal Furet, Urs Sequin, Peter Traxler
exaly  

Drug–drug interactions in patients receiving tyrosine kinase inhibitors

Journal of Oncology Pharmacy Practice, 2018
Alison P Duffy
exaly  

Inhibitors of brutons tyrosine kinase

2012
HONIGBERG LEE, VERNER ERIK, PAN ZHENGYING, MODY TARAK   +3 more
openaire   +10 more sources

Novel FLT3 tyrosine kinase inhibitors

Expert Opinion on Investigational Drugs, 2003
Mark J Levis, Donald Small
exaly  

INHIBITORS OF TYROSINE KINASES

2004
BREITENSTEIN WERNER, FURET PASCAL, JACOB SANDRA, MANLEY PAUL W   +3 more
openaire   +11 more sources

Inhibitors of bruton's tyrosine kinase

2015
DOMINIQUE ROMYR, KONG NORMAN, LOU YAN, LOPEZ-TAPIA FRANCISCO JAVIER, SO SUNG-SAU   +4 more
  +17 more sources

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio de Vito   +2 more
exaly  

Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer

Journal of Thoracic Oncology, 2012
Hiroyuki Yasuda, Daniel B Costa, Lorena Lobo De Figueiredo Pontes   +2 more
exaly  

Tyrosine kinase inhibitors

2018
HOLLAND SACHA, SINGH RAJINDER, BHAMIDIPATI SOMASEKHAR, DING PINGYU, KOLLURI RAO, DARWISH IHAB, MASUDA ESTEBAN, YU JIAXIN   +7 more
openaire   +5 more sources